Attached files

file filename
S-1/A - FORM S-1/A AMENDMENT #4 - ABEONA THERAPEUTICS INC.s1a-112310.htm
EX-5.1 - OPINION OF BINGHAM MCCUTCHEN LLP - ABEONA THERAPEUTICS INC.ex_5-1.htm
EX-10.30 - FORM OF WARRANT - ABEONA THERAPEUTICS INC.ex_10-30.htm
EX-10.32 - PLACEMENT AGENT AGREEMENT - ABEONA THERAPEUTICS INC.ex_10-32.htm
EX-10.31 - FORM OF SECURITIES PURCHASE AGREEMENT - ABEONA THERAPEUTICS INC.ex_10-31.htm
 


CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM




We have issued our report dated March 22, 2010, accompanying the consolidated financial statements of Access Pharmaceuticals, Inc., included in the Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 23, 2010, which is included in this Registration Statement. We consent to the inclusion in the Pre-effective Amendment No. 4 to the Registration Statement of Access Pharmaceuticals, Inc. on Form S-1 of the aforementioned report. We also consent to the reference to our firm under the heading "Experts" in such Registration Statement.

/s/ Whitley Penn LLP
 
 
Dallas, Texas
November 23, 2010